Gee-Hong Kuo
Drug Discovery Division
Johnson and Johnson Pharmaceutical Research and Development
L.L.C.
1000 Route 202
USA
Name/email consistency: high
- Synthesis and discovery of pyrazine-pyridine biheteroaryl as a novel series of potent vascular endothelial growth factor receptor-2 inhibitors. Kuo, G.H., Wang, A., Emanuel, S., Deangelis, A., Zhang, R., Connolly, P.J., Murray, W.V., Gruninger, R.H., Sechler, J., Fuentes-Pesquera, A., Johnson, D., Middleton, S.A., Jolliffe, L., Chen, X. J. Med. Chem. (2005)
- Synthesis and identification of [1,3,5]triazine-pyridine biheteroaryl as a novel series of potent cyclin-dependent kinase inhibitors. Kuo, G.H., Deangelis, A., Emanuel, S., Wang, A., Zhang, Y., Connolly, P.J., Chen, X., Gruninger, R.H., Rugg, C., Fuentes-Pesquera, A., Middleton, S.A., Jolliffe, L., Murray, W.V. J. Med. Chem. (2005)
- Synthesis and structure-activity relationships of pyrazine-pyridine biheteroaryls as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitors. Kuo, G.H., Prouty, C., Wang, A., Emanuel, S., Deangelis, A., Zhang, Y., Song, F., Beall, L., Connolly, P.J., Karnachi, P., Chen, X., Gruninger, R.H., Sechler, J., Fuentes-Pesquera, A., Middleton, S.A., Jolliffe, L., Murray, W.V. J. Med. Chem. (2005)
- Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors. Kuo, G.H., Prouty, C., DeAngelis, A., Shen, L., O'Neill, D.J., Shah, C., Connolly, P.J., Murray, W.V., Conway, B.R., Cheung, P., Westover, L., Xu, J.Z., Look, R.A., Demarest, K.T., Emanuel, S., Middleton, S.A., Jolliffe, L., Beavers, M.P., Chen, X. J. Med. Chem. (2003)
